FDA Approves Eydenzelt, a Biosimilar for Eye Drug Eylea

The U.S. FDA has approved Eydenzelt, a biosimilar drug from Celltrion, for treating major retinal diseases like Wet AMD, offering a new, affordable option.

By Jessica Miller